Sinopharm Group

(OTC) SHTDY

Current Price$11.88

Market Cap$3.19B

Since IPO (2016)-31%

5 Year-6%

1 Year+6%

1 Month-9%

Sinopharm Group Financials at a Glance

Market Cap

$3.19B

Revenue (TTM)

$1.15T

Net Income (TTM)

$14.13B

EPS (TTM)

$1.60

P/E Ratio

7.45

Dividend

$0.47

Beta (Volatility)

0.35 (Low)

Dividend

$0.47

Beta (Volatility)

0.35 (Low)

Price

$11.88

Volume

62,090

Open

$11.61

Price

$11.88

Volume

62,090

Open

$11.61

Previous Close

$11.88

Daily Range

$11.61 - $11.88

52-Week Range

$11.40 - $14.87

Dividend

$0.47

Beta (Volatility)

0.35 (Low)

Price

$11.88

Volume

62,090

Open

$11.61

Previous Close

$11.88

Daily Range

$11.61 - $11.88

52-Week Range

$11.40 - $14.87

SHTDY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sinopharm Group

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

94,910

Website

ir.sinopharmgroup.com.cn

Headquarters

Shanghai, 200023, CN

SHTDY Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

11%

Return on Assets

Earnings Yield

13.42%

Dividend Yield

3.95%

Payout Ratio

59.70%

Stock Overview

Market Cap

$3.19B

Shares Outstanding

268.36M

Volume

62.09K

Avg. Volume

61.21K

Financials (TTM)

Gross Profit

$40.09B

Operating Income

$16.21B

EBITDA

$20.38B

Operating Cash Flow

$14.14B

Capital Expenditure

$1.62B

Free Cash Flow

$12.52B

Cash & ST Invst.

$61.60B

Total Debt

$108.65B

Sinopharm Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$283.78B

-4.0%

Gross Profit

$20.70B

-18.0%

Gross Margin

7.29%

N/A

Market Cap

$3.19B

N/A

Market Cap/Employee

$29.46K

N/A

Employees

108,217

N/A

Net Income

$3.62B

-26.8%

EBITDA

$11.06B

-18.0%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$47.05B

-371.8%

Accounts Receivable

$206.78B

+11.3%

Inventory

$63.38B

+5.6%

Long Term Debt

$6.14B

-64.4%

Short Term Debt

$102.51B

+81.3%

Return on Assets

1.81%

N/A

Return on Invested Capital

11.28%

N/A

Free Cash Flow

$47.30B

-20.2%

Operating Cash Flow

$48.25B

-20.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SSMXYSysmex Corporation

SSMXYSysmex Corporation$8.41-3.56%

SHPMYShanghai Pharmaceuticals Holding Co., Ltd

SHPMYShanghai Pharmaceuticals Holding Co., Ltd$7.60+0.00%

WILLFDemant A/S

WILLFDemant A/S$31.15+0.00%

WILYYDemant A/S

WILYYDemant A/S$16.40+2.50%

TRSBF3SBio Inc.

TRSBF3SBio Inc.$2.83+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

RBLXRoblox

RBLXRoblox$45.13-0.18%

Questions About SHTDY

What is the current price of Sinopharm Group?

Sinopharm Group is trading at $11.88 per share.

What is the 52-week range for Sinopharm Group?

Over the past 52 weeks, Sinopharm Group has traded between $11.40 and $14.87.

How much debt does Sinopharm Group have?

As of the most recent reporting period, Sinopharm Group reported total debt of $14.35B.

How much cash does Sinopharm Group have on hand?

Sinopharm Group reported $8.43B in cash and cash equivalents in its most recent financial results.

What is Sinopharm Group’s dividend yield?

Sinopharm Group currently has a dividend yield of 3.95%.

Sinopharm Group

Sinopharm Group Financials at a Glance

SHTDY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sinopharm Group

SHTDY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sinopharm Group Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SHTDY

What is the current price of Sinopharm Group?

What is the 52-week range for Sinopharm Group?

How much debt does Sinopharm Group have?

How much cash does Sinopharm Group have on hand?

What is Sinopharm Group’s dividend yield?

Premium Investing Services